Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity
about
A new world malaria map: Plasmodium falciparum endemicity in 2010A long neglected world malaria map: Plasmodium vivax endemicity in 2010Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmissionPrimaquine or other 8-aminoquinoline for reducing P. falciparum transmissionClimate change and the global malaria recessionMathematical Modelling to Guide Drug Development for Malaria EliminationMathematical models for a new era of malaria eradicationReducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategiesMalaria's missing number: calculating the human component of R0 by a within-host mechanistic model of Plasmodium falciparum infection and transmissionImpact of Schistosoma mansoni on malaria transmission in Sub-Saharan AfricaTowards the elimination of malaria in South Africa: a review of surveillance data in Mutale Municipality, Limpopo Province, 2005 to 2010Modeling the risk of malaria for travelers to areas with stable malaria transmissionStable and unstable malaria hotspots in longitudinal cohort studies in Kenya.Interrupting malaria transmission: quantifying the impact of interventions in regions of low to moderate transmissionField efficacy of a new mosaic long-lasting mosquito net (PermaNet 3.0) against pyrethroid-resistant malaria vectors: a multi centre study in Western and Central Africa.Tolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malariaModelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children.Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.Monitoring, characterization and control of chronic, symptomatic malaria infections in rural Zambia through monthly household visits by paid community health workersReduced risk of malaria parasitemia following household screening and treatment: a cross-sectional and longitudinal cohort studyEpidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and eliminationThe story of artesunate-mefloquine (ASMQ), innovative partnerships in drug development: case study.The role of mathematical modelling in guiding the science and economics of malaria eliminationP. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model.The impact of artemisinin combination therapy and long-lasting insecticidal nets on forest malaria incidence in tribal villages of India, 2006-2011Ranking of elimination feasibility between malaria-endemic countries.Artemether combined with shRNA interference of vascular cell adhesion molecule-1 significantly inhibited the malignant biological behavior of human glioma cells.Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.A high-throughput screen targeting malaria transmission stages opens new avenues for drug developmentLead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies.Comparing the impact of artemisinin-based combination therapies on malaria transmission in sub-Saharan AfricaCommunity screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis.Mathematical models of malaria--a review.A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania.Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.Antiparasitic chemotherapy: from genomes to mechanisms.Measuring the association between artemisinin-based case management and malaria incidence in southern Vietnam, 1991-2010.Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmissionRoutine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study.
P2860
Q17485680-F4E2AE42-B250-4455-AEC6-B7687590A84FQ21144495-5DEFB6F3-23F0-487F-9A8B-2B25A1FEE4C0Q24188070-B8B816CE-FC5C-4A32-9A93-D5D0B01AD33DQ24193716-69B9B396-0292-4F45-8E2B-04441E3A0B86Q24634284-0E98FB6B-82CC-4059-A5DF-AAA523EC5144Q28067367-689FA1CB-D021-44E1-8587-2449FDFDFA3AQ28474133-ACC9F535-E43B-4A02-9848-A0B961C296ABQ28475084-2E85243C-2DFC-4DEE-8E19-20AA6C7B733FQ28486274-CA681CA2-5480-408F-857F-BD36306FD19BQ28543825-1494300F-CF4B-47E4-92EA-1C982DDC93A6Q28709102-94AFAB03-9D25-4CF2-A0B3-69E65609364CQ33590177-2D59845F-F071-43CA-ABC9-20C028F9B9F6Q33631268-3242EC52-8C5E-468E-8446-10050D370A3FQ33769869-7D363ACD-BA96-4C8D-A7AC-A8A316AB30A6Q33878914-0223E542-AEC3-4152-8720-47D37BA4EB00Q33880614-B9B4BA64-C67F-46A6-8228-CC9D6239781CQ33886209-2D0C26E1-DB57-49E2-9FFE-6B47F886723FQ33898575-77B80B1D-6001-418F-86A4-42575D9D2C30Q33960088-837278FE-44B6-458B-8EA1-6D44984278C8Q34154816-35A25E52-F8A5-4146-B62B-7B07C2C515B9Q34177472-41657CB5-39C6-4C69-82CF-21FDA6DFEAD5Q34329292-6FDCDB47-65B3-46B7-8ACB-F37D67C4CCFDQ34415327-4D393256-9F96-4FB9-8056-9C970E618D1AQ34427744-EB30D587-51CE-4A76-A8ED-9206943F74E4Q34599413-5F9047A4-9665-4467-88EA-8A754534B52DQ34605561-D9A9003E-E073-40C2-BE10-5ED7A73D57D8Q34674201-465C0624-23BD-4062-AE1D-E4BAC12D2519Q34677891-F8AD9110-FEF7-446B-8BF7-93C124D9D6D0Q34833899-56282AFD-B990-40C8-B26E-06B814B653F3Q34922792-3261D9C6-C114-4B0C-883E-176953C72C04Q35004430-DF78D95F-191E-4BF8-9126-44E9F0867911Q35150299-28477A34-F492-4F4A-9C66-ACE94839AA9CQ35179184-A51E003A-308E-4A3F-9876-072B04436AFAQ35183410-7D6F55F8-06AE-4820-90C7-ACCBF26CAA9EQ35203887-E11A15BF-30D0-4C99-B208-C81AF4BD1289Q35224221-1D043681-5CFF-47B2-9C63-6469FC574201Q35238319-393D2B80-1652-4C91-AFCE-A9CA7119F92DQ35272776-8C38F602-AFB3-4BF1-8237-D18AD7E32ADEQ36353796-E4542237-71A2-41CD-87DB-C90117F3C58FQ36483241-64C7C7B9-63AA-4D5E-ABEF-B0F66412FB66
P2860
Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Modelling the impact of artemi ...... malaria transmission intensity
@ast
Modelling the impact of artemi ...... malaria transmission intensity
@en
Modelling the impact of artemi ...... malaria transmission intensity
@nl
type
label
Modelling the impact of artemi ...... malaria transmission intensity
@ast
Modelling the impact of artemi ...... malaria transmission intensity
@en
Modelling the impact of artemi ...... malaria transmission intensity
@nl
prefLabel
Modelling the impact of artemi ...... malaria transmission intensity
@ast
Modelling the impact of artemi ...... malaria transmission intensity
@en
Modelling the impact of artemi ...... malaria transmission intensity
@nl
P2860
P50
P921
P3181
P1433
P1476
Modelling the impact of artemi ...... malaria transmission intensity
@en
P2860
P304
e226; discussion e226
P3181
P356
10.1371/JOURNAL.PMED.0050226
P407
P577
2008-11-25T00:00:00Z